Filed on behalf of dozens of former Department of Justice officials, this brief emphasizes that the Comstock law’s scope is irrelevant to the validity of FDA’s actions on mifepristone and FDA’s actions still comply with Comstock laws, however interpreted.

This brief was one of many filed in Alliance for Hippocratic Medicine v. FDA. For more information on the case, click here.